Učitavanje...
Anti-Mesothelin CAR T cell therapy for malignant mesothelioma
Malignant mesothelioma (MM) is a treatment-resistant tumor originating in the mesothelial lining of the pleura or the abdominal cavity with very limited treatment options. More effective therapeutic approaches are urgently needed to improve the poor prognosis of MM patients. Chimeric Antigen Recepto...
Spremljeno u:
| Izdano u: | Biomark Res |
|---|---|
| Glavni autori: | , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
BioMed Central
2021
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7885509/ https://ncbi.nlm.nih.gov/pubmed/33588928 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40364-021-00264-1 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|